Your browser does not support JavaScript or JavaScript is not enabled. Without JavaScript some functions of this webapplication may be disabled or cause error messages. To enable JavaScript, please consult the manual of your browser or contact your system administrator.

Project

Further development of mRNA Galsomes as nanovaccines for cancer immunotherapy: combination with checkpoint inhibition and translation to the clinic.

Information

Project Team

Outputs and Outcomes

Promotor

Stefaan De Smedt

Department of Pharmaceutics

Copromotor

Heleen Dewitte

Department of Pharmaceutics (until 20 December 2020)

Fellow

Sofie Meulewaeter

Department of Pharmaceutics